Altido Therapeutics
PrivateLast Round
Seed
Jan 1, 2026
Total Funding Raised
$12.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Altido Therapeutics operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Seed round in January 2026.
Altido Therapeutics is a biotechnology company that develops cell-based immunotherapies, specifically CAR-TEAM therapies, to treat difficult-to-treat solid tumors like glioblastoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altido Therapeutics Comparables
Compare Altido Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlioCART GmbH | 88% | |
| Adaptin Bio | 84% | |
| Imvax | 83% |
For institutional investors. Book with your work email.
Altido Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Altido Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mass General Brigham Innovation | Seed |
| ARCH Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 82% MoM.
- Jan 1, 2026
$13M round led by ARCH Venture Partners.
For institutional investors. Book with your work email.
Altido Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Altido Therapeutics's valuation, stock price, and market status.
Is Altido Therapeutics a public or private company?
Altido Therapeutics is a private company.
What is the current stock price of Altido Therapeutics?
Altido Therapeutics is a private company, so its shares have no public market price. Caplight tracks Altido Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Altido Therapeutics worth (valuation)?
Valuation information for Altido Therapeutics is not publicly available.
Can I buy Altido Therapeutics stock?
Altido Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Altido Therapeutics's last funding round?
Altido Therapeutics's most recent funding round was Seed on January 1, 2026.
Who are the main investors in Altido Therapeutics?
Key investors in Altido Therapeutics include ARCH Venture Partners.
Will Altido Therapeutics IPO soon?
No public IPO plans have been announced for Altido Therapeutics.
How can I track Altido Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Altido Therapeutics's shares on secondary markets.